Efficacy and safety of saxagliptin: replies received in SAVOR trial

Cover Page

Cite item

Full Text

Abstract

Interview with Shestakova Marina Vladimirovna - MD, professor, corresponding member of RAS, director of Institute ofDiabetes FSI Endocrinology Research Center of the Ministry of Health of the Russian Federation

About the authors

- -

References


Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies